QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 seer-demonstrates-how-proteograph-platform-advances-disease-research-at-american-society-of-human-genetics-meeting

Seer, Inc. (NASDAQ:SEER), the pioneer and trusted partner for deep, unbiased proteomic insights, today announced its participat...

 seer-affirms-fy2025-sales-guidance-of-17000m-18000m-vs-17650m-est

Seer (NASDAQ:SEER) affirms FY2025 sales outlook from $17.000 million-$18.000 million to $17.000 million-$18.000 million vs $17....

 seer-q2-eps-033-beats-037-estimate-sales-410m-beat-375m-estimate

Seer (NASDAQ:SEER) reported quarterly losses of $(0.33) per share which beat the analyst consensus estimate of $(0.37) by 10.81...

 reported-june-1-2025-seer-and-korea-university-launch-large-scale-study-using-proteograph-one-assay-and-mass-spectrometry-to-identify-early-onset-cancer-biomarkers-in-young-adults

First-of-its-kind study will use Seer's next-generation workflow to identify early-onset cancer biomarkers and power deep, ...

 seer-sees-fy2025-sales-17000m-18000m-vs-1903m-est

Seer (NASDAQ:SEER) sees FY2025 sales of $17.000 million-$18.000 million vs $19.03 million analyst estimate.

 seer-q4-eps-037-misses-035-estimate-sales-400m-beat-395m-estimate

Seer (NASDAQ:SEER) reported quarterly losses of $(0.37) per share which missed the analyst consensus estimate of $(0.35) by 5.7...

 seer-q3-2024-gaap-eps-035-misses-029-estimate-sales-4032m-beat-3150m-estimate

Seer (NASDAQ:SEER) reported quarterly losses of $(0.35) per share which missed the analyst consensus estimate of $(0.29) by 20....

 seer-affirms-fy2024-sales-guidance-from-1300m-1500m-to-1300m-1500m

Seer (NASDAQ:SEER) affirms FY2024 sales outlook from $13.00 million-15.00 million to $13.00 million-15.00 million.

 morgan-stanley-maintains-equal-weight-on-seer-lowers-price-target-to-3

Morgan Stanley analyst Yuko Oku maintains Seer (NASDAQ:SEER) with a Equal-Weight and lowers the price target from $7 to $3.

 seer-q2-2024-gaap-eps-035-beats-036-estimate-sales-3072m-miss-3200m-estimate

Seer (NASDAQ:SEER) reported quarterly losses of $(0.35) per share which beat the analyst consensus estimate of $(0.36) by 2.78 ...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION